|
Nov 13
|
Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program
|
|
Sep 6
|
Teva to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
|
|
Sep 6
|
Teva to Present Data for AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, AUSTEDO® (deutetrabenazine) Tablets and UZEDY™ (risperidone) Extended-Release Injectable Suspension at Psych Congress 2023
|
|
Jun 30
|
Teva’s 3rd interim analysis of PEARL real-world study on AJOVY® (fremanezumab) reveals sustained long-term effectiveness in reducing frequency, duration and severity of attacks in patients with chronic and episodic migraine
|
|
Jun 28
|
Patients Can’t Get Some Lifesaving Drugs. What’s Causing the Shortages.
|